Dena R Ramey Selected Research

Osteoarthritis

5/2005

The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dena R Ramey Research Topics

Disease

8	Coronary Disease (Coronary Heart Disease) 01/2014 - 01/2006
5	Cardiovascular Diseases (Cardiovascular Disease) 07/2017 - 09/2013
3	Hypercholesterolemia 07/2017 - 01/2008
3	Vascular Diseases (Vascular Disease) 01/2014 - 03/2010
2	Atherosclerosis 07/2017 - 01/2006
2	Diabetes Mellitus 09/2013 - 01/2008
1	Atherosclerotic Plaque (Atheroma) 12/2011
1	Peripheral Arterial Disease 12/2011
1	Sitosterolemia 01/2006
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2006
1	Peptic Ulcer (Peptic Ulcers) 05/2005
1	Osteoarthritis 05/2005
1	Hemorrhage 05/2005
1	Rheumatoid Arthritis 05/2005
1	Ankylosing Spondylitis 05/2005

Drug/Important Bio-Agent (IBA)

10	oxidized low density lipoproteinIBA 07/2017 - 01/2008
9	LDL CholesterolIBA 07/2017 - 03/2010
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014 - 01/2008
4	CholesterolIBA 04/2015 - 01/2006
3	Simvastatin (Zocor)FDA LinkGeneric 07/2017 - 01/2008
3	LipidsIBA 01/2016 - 11/2010
2	Biomarkers (Surrogate Marker)IBA 07/2017 - 12/2011
2	Ezetimibe (Zetia)FDA Link 07/2017 - 01/2008
1	Messenger RNA (mRNA)IBA 12/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2011
1	CytokinesIBA 12/2011
1	SterolsIBA 01/2008
1	Atorvastatin (Lipitor)FDA Link 01/2008
1	Triglycerides (Triacylglycerol)IBA 01/2008
1	Proteins (Proteins, Gene)FDA Link 01/2008
1	gamma-sitosterol (beta-sitosterol)IBA 01/2006
1	EtoricoxibIBA 05/2005
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2005

Therapy/Procedure

7	Therapeutics 01/2016 - 01/2008
1	Secondary Prevention 01/2016